Kupershmidt Sabina, Yang Iris C-H, Sutherland Margaret, Wells K Sam, Yang Tao, Yang Ping, Balser Jeffrey R, Roden Dan M
Department of Pharmacology, 561A PRB, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA.
Cardiovasc Res. 2002 Oct;56(1):93-103. doi: 10.1016/s0008-6363(02)00498-4.
Co-expression of the KvLQT1 and minK potassium channel subunits is required to recapitulate I(Ks), the slow component of the cardiac delayed rectifier current, and mutations in either gene cause the congenital Long QT syndrome. It is becoming increasingly well-recognized that multiprotein channel complexes containing proteins capable of modulating channel function assemble at the plasma membrane. Thus, the aim of our study was to identify proteins involved in I(Ks) modulation.
Using a yeast-two-hybrid screen with the intracytoplasmic C-terminus of minK as bait, we identified the cardiac-enriched four-and-a-half LIM domain-containing protein (fhl2) as a potential minK partner. We show interaction between the two proteins in GST pulldown assays and demonstrate overlapping subcellular localization using immunocytochemistry of transfected cells supporting a potential interaction. At the functional level, expression of KvLQT1and minK in HEK cells, which lack endogenous fhl2 protein, generated I(Ks) only when fhl2 was co-expressed. By contrast, in CHO-K1 cells, which express fhl2 endogenously, I(Ks) was suppressed by anti-fhl2 antisense which did not affect the currents generated by KvLQT1alone.
These data indicate that at least in heterologous cells, the generation of I(Ks) requires fhl2 as an additional protein component.
心脏延迟整流电流的慢成分I(Ks)的重现需要KvLQT1和minK钾通道亚基的共表达,任一基因的突变都会导致先天性长QT综合征。人们越来越认识到,包含能够调节通道功能的蛋白质的多蛋白通道复合物在质膜上组装。因此,我们研究的目的是鉴定参与I(Ks)调节的蛋白质。
以minK的胞质内C末端为诱饵进行酵母双杂交筛选,我们鉴定出富含心脏的含四个半LIM结构域的蛋白(fhl2)作为minK的潜在伙伴。我们在GST下拉试验中显示了这两种蛋白之间的相互作用,并通过对转染细胞进行免疫细胞化学证明了它们重叠的亚细胞定位,支持了潜在的相互作用。在功能水平上,在缺乏内源性fhl2蛋白的HEK细胞中,只有当fhl2共表达时,KvLQT1和minK的表达才会产生I(Ks)。相比之下,在天然表达fhl2的CHO-K1细胞中,抗fhl2反义核酸抑制了I(Ks),但不影响单独由KvLQT1产生的电流。
这些数据表明,至少在异源细胞中,I(Ks)的产生需要fhl2作为额外的蛋白成分。